Oaktree Acquisition Corp. III Life Sciences

Oaktree Acquisition Corp. III Life Sciences, trading under the ticker OACC, is a blank-check company sponsored by Oaktree Capital Management, the Los Angeles-based global alternative investment firm. The vehicle targets acquisition candidates in the life sciences sector, encompassing biotechnology, medical devices, diagnostics, and related healthcare services. OACC went public in 2024 and remains in the search phase, as evidenced by its Form 10-Q filed with the SEC on August 12, 2025, covering activity through the second quarter and indicating no definitive business combination has been announced. For full filing history, sponsor profiles, deal timelines, and real-time SPAC analytics on OACC and the broader market, sign up for complete access at SpacDesk.